Literature DB >> 17064746

Prevalence of urinary schistosomiasis and HIV in females living in a rural community of Zimbabwe: does age matter?

P D Ndhlovu1, T Mduluza, E F Kjetland, N Midzi, L Nyanga, S G Gundersen, H Friis, E Gomo.   

Abstract

A cross-sectional study was conducted on 544 women living in Mupfure rural area of Zimbabwe to determine whether infection with urinary schistosomiasis is associated with HIV infection. Schistosoma haematobium infection was examined in urine samples and HIV infection was determined in sera. The prevalence of S. haematobium infection was highest (60%) in women below 20 years of age and declined to 29% in the oldest age group (test for trends, P<0.001). Overall, women infected with urinary schistosomiasis had an HIV prevalence of 33.3%, whilst women without urinary schistosomiasis had an HIV prevalence of 25.6% (chi(2), P=0.053). Women above the age of 35 years and infected with urinary schistosomiasis had a significantly higher HIV prevalence (37.5%) than those without urinary schistosomiasis (16.8%; chi(2), P<0.001).

Entities:  

Mesh:

Year:  2006        PMID: 17064746     DOI: 10.1016/j.trstmh.2006.08.008

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  27 in total

1.  Proportion of Urinary Schistosomiasis among HIV-Infected Subjects in Benin City, Nigeria.

Authors:  Akinbo Frederick Olusegun; Okaka Christopher Ehis; Omoregie Richard
Journal:  Oman Med J       Date:  2011-05

Review 2.  Parasites and poverty: the case of schistosomiasis.

Authors:  Charles H King
Journal:  Acta Trop       Date:  2009-12-04       Impact factor: 3.112

3.  Real-time polymerase chain reaction for detection of Schistosoma DNA in small-volume urine samples reflects focal distribution of urogenital Schistosomiasis in primary school girls in KwaZulu Natal, South Africa.

Authors:  Pavitra Pillay; Myra Taylor; Siphosenkosi G Zulu; Svein G Gundersen; Jaco J Verweij; Pytsje Hoekstra; Eric A T Brienen; Elisabeth Kleppa; Eyrun F Kjetland; Lisette van Lieshout
Journal:  Am J Trop Med Hyg       Date:  2014-01-27       Impact factor: 2.345

4.  Detectable urogenital schistosome DNA and cervical abnormalities 6 months after single-dose praziquantel in women with Schistosoma haematobium infection.

Authors:  Jennifer A Downs; Rodrick Kabangila; Jaco J Verweij; Hyasinta Jaka; Robert N Peck; Samuel E Kalluvya; John M Changalucha; Warren D Johnson; Lisette van Lieshout; Daniel W Fitzgerald
Journal:  Trop Med Int Health       Date:  2013-09       Impact factor: 2.622

Review 5.  Effect of helminth-induced immunity on infections with microbial pathogens.

Authors:  Padmini Salgame; George S Yap; William C Gause
Journal:  Nat Immunol       Date:  2013-11       Impact factor: 25.606

6.  Interactions of Schistosoma and HIV in Sub-Saharan Africa: A Systematic Review.

Authors:  Briana D Furch; John R Koethe; Violet Kayamba; Douglas C Heimburger; Paul Kelly
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345

7.  Genetic manipulation of Schistosoma haematobium, the neglected schistosome.

Authors:  Gabriel Rinaldi; Tunika I Okatcha; Anastas Popratiloff; Mary A Ayuk; Sutas Suttiprapa; Victoria H Mann; Yung-san Liang; Fred A Lewis; Alex Loukas; Paul J Brindley
Journal:  PLoS Negl Trop Dis       Date:  2011-10-11

Review 8.  Examining the relationship between urogenital schistosomiasis and HIV infection.

Authors:  Pamela Sabina Mbabazi; Olivia Andan; Daniel W Fitzgerald; Lester Chitsulo; Dirk Engels; Jennifer A Downs
Journal:  PLoS Negl Trop Dis       Date:  2011-12-06

9.  Empowering women and improving female reproductive health through control of neglected tropical diseases.

Authors:  Peter J Hotez
Journal:  PLoS Negl Trop Dis       Date:  2009-11-24

10.  Downregulation of MIP-1alpha/CCL3 with praziquantel treatment in Schistosoma haematobium and HIV-1 co-infected individuals in a rural community in Zimbabwe.

Authors:  Rbl Zinyama-Gutsire; E Gomo; P Kallestrup; C Erikstrup; H Ullum; A E Butterworth; S Munyati; T Mduluza
Journal:  BMC Infect Dis       Date:  2009-10-23       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.